Poliacel

Страна: Новая Зеландия

Язык: английский

Источник: Medsafe (Medicines Safety Authority)

Активный ингредиент:

Diphtheria toxoid, adsorbed 15 Lf U; Pertactin 3ug (adsorbed); Pertussis filamentous haemagglutinin 20ug (adsorbed); Pertussis fimbriae 2+3 5ug (adsorbed); Pertussis toxoid, adsorbed 20ug; Polio virus type 1 40 DAgU (inactivated); Polio virus type 2 8 DAgU (inactivated); Polio virus type 3 32 DAgU (inactivated); Tetanus toxoid, adsorbed 5 Lf U; Haemophilus influenzae type b polysaccharide 10ug (conjugated to tetanus protein (18-30µg))

Доступна с:

sanofi-aventis new zealand limited

ИНН (Международная Имя):

Diphtheria toxoid, adsorbed 15 Lf U

Фармацевтическая форма:

Combination

состав:

Active: Diphtheria toxoid, adsorbed 15 Lf U Pertactin 3ug (adsorbed) Pertussis filamentous haemagglutinin 20ug (adsorbed) Pertussis fimbriae 2+3 5ug (adsorbed) Pertussis toxoid, adsorbed 20ug Polio virus type 1 40 DAgU (inactivated) Polio virus type 2 8 DAgU (inactivated) Polio virus type 3 32 DAgU (inactivated) Tetanus toxoid, adsorbed 5 Lf U Excipient: Aluminium phosphate Bovine serum albumin Formaldehyde Glutaral Neomycin Phenoxyethanol Polymyxin B Polysorbate 80 Water for injection Active: Haemophilus influenzae type b polysaccharide 10ug (conjugated to tetanus protein (18-30µg)) Excipient: Sucrose Trometamol

Штук в упаковке:

Combination pack, 1x Act-HIB, 1x Quadracel, 1 dose unit

класс:

Prescription

Тип рецепта:

Prescription

Производитель:

Sanofi Pasteur Limited

Терапевтические показания :

POLIACEL® is indicated for primary immunisation of children from the age of 2 months to 12 months against diphtheria, tetanus, whooping cough, poliomyelitis and invasive Haemophilus influenzae type b disease. POLIACEL® is also indicated for the fourth dose for children from 15 to 20 months who have been immunised previously with up to three doses of diphtheria, tetanus, pertussis, polio and Haemophilus influenzae type b disease vaccines.

Обзор продуктов:

Package - Contents - Shelf Life: Combination pack, 1x Act-HIB, 1x Quadracel - 1 dose units - 30 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Combination pack, 5x Act-HIB, 5x Quadracel - 5 dose units - 30 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Vial, glass, Quadracel component - 1 dose units - 30 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Vial, glass, Act-HIB component - 1 dose units - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Дата Авторизация:

2001-02-19